This activity is provided by Med Learning Group.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Copyright © 2024 Med Learning Group. Built by Divigner. All Rights Reserved.
Glossary of FDA Approved Drugs for Melanoma
Glossary of FDA approved drugs for Advanced Melanoma
| Generic name | Trade name | Link to prescribing information |
|---|---|---|
| Atezolizumab | Tecentriq® | https://www.tecentriq.com/melanoma.html |
| Binimetinib | Mektovi® | https://www.braftovimektovi.com/ |
| Cobimetinib | Cotellic® | https://www.cotellic.com/ |
| Dabrafenib | Tafinlar® | https://www.us.tafinlarmekinist.com/ |
| Encorafenib | Braftovi® | https://www.braftovimektovi.com/ |
| Entrectinib* | RozlytrekTM | https://www.rozlytrek.com/ |
| Interleukin-2 | Proleukin® (Aldesleukin) | https://proleukin.com/ |
| Ipilimumab | Yervoy® | https://www.yervoy.com/ |
| Larotectinib* | Vitrakvi® | https://hcp.vitrakvi-us.com/ |
| Nivolumab | Opdivo® | https://www.opdivo.com/ |
| Nivolumab plus Relatlimab | OpdualagTM | https://www.opdualag.com/ |
| Pembrolizumab | Keytruda® | https://www.keytruda.com/melanoma/ |
| Talimogene laherparepvec | Imlygic® | https://www.imlygic.com/ |
| Trametinib | Mekinist® | https://www.us.tafinlarmekinist.com/ |
| Vemurafenib | Zelboraf® | https://www.gene.com/patients/medicines/zelboraf |
*for metastatic melanoma with an NTRK fusion (mutation)
